Sera Prognostics, Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Chemistry, Immunoassay
  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
  • Digital Health
    • Disease Management
See more in Biomedtracker

Latest on Sera Prognostics, Inc.

In Vivo

Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017

 
• By Amanda Micklus and Maureen Riordan

Device Transactions Financing by device companies in the first quarter of 2017 totaled $2.3 billion, slightly lower than Q4 2016's $2.4 billion. Notably, early-stage venture capital fundraising made u

In Vivo

Deals Shaping The Medical Industry, February 2017

 
• By Steven Muntner, Amanda Micklus, Beth Allan, Maureen Riordan, and Deanna Kamienski

IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. Tulip Diagnostics Pvt. Ltd. PerkinElmer Inc. is acquiring Indian firm Tulip Diagnostics Pvt. Ltd. (Jan.) Tulip focuses on assay sys

Medtech Insight

Pacts In Medtech: January/February 2017

 
• By Beth Allan, Deanna Kamienski, and Maureen Riordan

The first two months of 2017 saw a flurry of alliances that involved Asian players, whose partnerships with western counterparts have noticeably risen in recent years. This is driven by companies in t

Scrip

Start-Up Execs On The Move, March 2015

 
• By Regina Paleski

Start-Up Execs Armetheon Inc. John (Jack) F. Glenn To: CFO (February) From: CFO, Solta Medical Inc. Phone: 650-646-3898 Bio Blast Pharma Ltd. Colin Foster To: Pres. & CEO (February) From: